Global Antivirals Market 2010-2025

The Research You Need - Just When You Need It

Questions? Chat Now! | research@infoedge.com

800.544.7337 | 617.969.9080

About Us | Contact |

Cart | Login

♦ See Other Reports About... Global market for antiviral drugs, CBRN detection systems, Leading antivirals drug companies , Healthcare , Pharmaceutical Industry , Market Forecasts

Free Industry Verticals Research

Report Code: VG-4077

Date: 2/2010

By: visiongain

In 2009, the global market for antiviral drugs attained total sales of over $28B. With hundreds of millions of people worldwide suffering from chronic or acute viral infections, there is enormous need for antiviral drugs. It is only in the past few decades that researchers have begun to find ways of combating viruses. Because viruses mutate rapidly and acquire drug-resistance, the antiviral pipeline needs to be continuously replenished with newer, better therapies, as this new market study notes.

Global Antivirals Market 2010-2025 forecasts how the global antivirals market will grow and change over the next 15 years. Visiongain predicts that the market will continue to expand, driven by significant unmet needs, expanding patient populations, better diagnostics and innovative new drugs, including combination therapies. This report offers detailed and extensive coverage of the principal antiviral drugs, with comprehensive sales forecasting at class and brand levels. It also provides up-to-date assessments of the most-exciting antiviral agents in development.

Comprehensive analysis of the antiviral pharmaceuticals market

Global Antivirals Market 2010-2025 critically examines that sector through a comprehensive review of primary and secondary information sources. This new report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints. There are over 75 tables and figures included, as well as two original interviews with relevant experts. The result is a comprehensive market- and industry-centered study, with detailed analyses and informed opinion to benefit your work.

Why you should buy this report

Purchasing this report gives you the following benefits:

Receive a comprehensive analysis of the prospects for antiviral drugs from 2010 to 2025, including predicted revenues, growth rates and other important data
Find out where the market is heading - both technologically and commercially - from the present onwards, both for the overall world market and for leading national markets
Discover the prospects for leading companies and disease classes, including sales revenues and market shares from 2010 onwards
Discover expert opinion from its original survey
Identify key R&D pipeline developments and up-and-coming products
Discover the drivers, restraints, competition and opportunities influencing the antivirals market
Discover prospects for Tamiflu, in light of the recent swine flu outbreak.

Visiongain’s research shows that new antiviral drugs have strong potential for commercial success if they are well-tolerated and more effective than existing products. The commercial potential and therapeutic expectations are high for R&D pipeline agents, with rapid technological advances.

Visiongain License Terms & Conditions

Report Licenses:
By submitting an order for a visiongain report product, the customer agrees and represents that they are buying for their own internal use only, and not for resale or export. Use of any visiongain report is also bound by the license type.

Single User License:
This license allows for use of a report by one person. This person may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Unless a Departmental License, a Site License or a Global Site License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same enterprise. Customers who infringe these license terms are liable for a Global Site license fee.

Departmental Licenses:
This license allows for use of a report by five people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Customers who infringe these license terms are liable for a Global Site license fee.

Site License:
This license allows for use of a report by an unlimited number of people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any person or persons outside of the enterprise location. Customers who infringe these license terms are liable for a Global Site license fee.

Global Site License:
This license allows for use of a report by an unlimited number of people within the same enterprise worldwide. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise. The buyer may load this report to their company intranet (but not the Internet) if they so wish.

♦ PURCHASE OPTIONS

		$2224	Single User License: Delivery of report PDF via e-mail with a single-user license. See details of this license option in the report Abstract.
		$4450	Departmental License: Delivery of report PDF via e-mail with a departmental license.See details of this license option in the report Abstract..
		$7418	Site License: Delivery of report PDF via e-mail with a Site License. See details of this license option in the report Abstract..
		$10387	Global Site License: Delivery of report PDF via e-mail with a Global Site License. See details of this license option in the report Abstract.